29 results
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Management Initiative (PAMI ... Analgesics - Agents and Dosing ... Medications #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Management Initiative (PAMI ... Chart - Agents and Dosing ... Conversion #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Pain Management and Dosing Guide

#Management #Pain #Pharmacology #Doses #Dosing
Management Initiative (PAMI ... Management and Dosing ... Pharmacology #Doses #Dosing ... #Guide #Tables ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Management Initiative (PAMI ... Relaxants - Agents and Dosing ... Medications #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Management Initiative (PAMI ... Distribution, Agents and Dosing ... Table - Lidocaine ... Medications #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Management Initiative (PAMI ... Medications #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Management Initiative (PAMI ... Medications #Doses #Dosing ... #Table #PAMI
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
Asthma, Asthma-COPD ... Overlap and COPD ... The diagnosis of COPD ... overlap; ICS = ... #Differences #Algorithm
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Reduce risk of COPD ... Therapy (LAMA/LABA/ICS ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... low, adding an ICS
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... of a patients COPD ... posts for the COPD ... treatment algorithm ... are the normal dosing